Azithromycin Extended-Release 2g Suspension from Japan
Single-dose 2g extended-release azithromycin suspension for gonorrhea treatment. Meets HTS 3004.20.00.45 as a prophylactic measured dose product containing azithromycin salts in retail packaging.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide bioequivalence studies for ANDA products matching innovator Zmax
• Ensure suspension viscosity specs for proper extended-release mechanism
• Declare as finished pharmaceutical, not bulk, to avoid reclassification